Skip to Main Content
Back to News

Lobbying Update: $50,000 of MCKESSON CORPORATION lobbying was just disclosed

None

$50,000 of MCKESSON CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness. Drug Shortages."

You can find more data on corporate lobbying on Quiver Quantitative.

MCK Congressional Stock Trading

Members of Congress have traded $MCK stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MCK stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MCK Insider Trading Activity

MCK insiders have traded $MCK stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $MCK stock by insiders over the last 6 months:

  • BRIAN S. TYLER (Chief Executive Officer) has made 0 purchases and 2 sales selling 7,506 shares for an estimated $4,455,298.
  • LEANN B SMITH (EVP & Chief HR Officer) has made 0 purchases and 2 sales selling 1,158 shares for an estimated $680,672.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MCK Hedge Fund Activity

We have seen 601 institutional investors add shares of MCK stock to their portfolio, and 816 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles